Evidence map›Paper›PMID 33114669›Full record

ArticleMolecules (Basel, Switzerland)2020

Coriolic Acid (13-(

Yu-Chan Ko, Hack Sun Choi, Ji-Hyang Kim, Su-Lim Kim, Bong-Sik Yun, Dong-Sun Lee

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. UHPLC-QTOF-MS Profiling of Chemical Constituents in POW9International journal of molecular sciences · 2026
    Article
  3. Molecular Docking and Drug-Likeness ofCurrent issues in molecular biology · 2025
    Article
  4. Article
  5. Plants (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Metabolomics andHeliyon · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yu-Chan KoInterdisciplinary Graduate Program in Advanced Convergence Technology and Science, Jeju National University, Jeju 63243, Korea.
Hack Sun ChoiSubtropical/Tropical Organism Gene Bank, Jeju National University, Jeju 63243, Korea.
Ji-Hyang KimInterdisciplinary Graduate Program in Advanced Convergence Technology and Science, Jeju National University, Jeju 63243, Korea.
Su-Lim KimInterdisciplinary Graduate Program in Advanced Convergence Technology and Science, Jeju National University, Jeju 63243, Korea.
Bong-Sik YunDivision of Biotechnology, College of Environmental and Bioresource Sciences, Chonbuk National University, Gobong-ro 79, Iksan 54596, Korea.
Dong-Sun LeeInterdisciplinary Graduate Program in Advanced Convergence Technology and Science, Jeju National University, Jeju 63243, Korea.ORCID 0000-0001-7816-6471
Jeju National University · KRJeonbuk National University · KR

Funding

National Research Foundation of Korea NRF-2016R1A6A1A03012862 and NRF-2020R1A2C1006316
6 · The paper itself

Abstract

Cancer stem cells have certain characteristics, such as self-renewal, differentiation, and drug resistance, which are related to tumor progression, maintenance, recurrence, and metastasis. In our study, we targeted breast cancer stem cells (BCSCs) using a natural compound, coriolic acid, from

Indexed as

ApoptosisBreast NeoplasmsChenopodiaceaeFatty Acids, UnsaturatedGene Expression Regulation, NeoplasticHumansMCF-7 CellsNeoplastic Stem CellsProto-Oncogene Proteins c-myccoriolic acidFatty Acids, UnsaturatedMYC protein, humanoctadecadienoic acidProto-Oncogene Proteins c-mycbreast cancer stem cells (BCSCs)c-Myccoriolic acidmammospheres

Identifiers

PMID33114669
PMCPMC7663198
OpenAlexW3097153951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.